1 |
Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials
|
Wetwittayakhlang P.; Bessissow T.; Lakatos P. |
2024 |
Review |
0 |
2 |
Comparing the Efficacy of Carboplatin plus 5-Fluorouracil, Cisplatin plus 5-Fluorouracil, and Best Supportive Care for Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Analysis from a Tertiary Hospital in Southern Thailand
|
Wonglhow J.; Wetwittayakhlang P.; Sunpaweravong P.; Sathitruangsak C.; Dechaphunkul A. |
2024 |
Article |
0 |
3 |
Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system
|
Bacsur P.; Wetwittayakhlang P.; Res?l T.; F?ldi E.; Vasas B.; Farkas B.; Rutka M.; Bessissow T.; Afif W.; B?lint A.; F?bi?n A.; Bor R.; Szepes Z.; Farkas K.; Lakatos P.; Moln?r T. |
2024 |
Article |
0 |
4 |
Monitoring of Inflammatory Bowel Disease in Pregnancy: A Review of the Different Modalities
|
Al-Jabri R.; Wetwittayakhlang P.; Lakatos P. |
2023 |
Review |
0 |
5 |
Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study
|
Wetwittayakhlang P.; Karkout K.; Wongcha-Um A.; Tselekouni P.; Al-Jabri R.; Afif W.; Wild G.; Bitton A.; Bessissow T. |
2023 |
Article |
0 |
6 |
Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study
|
Wetwittayakhlang P.; Verdon C.; Starr M.; Hahn G.; Golovics P.; Bessissow T.; Afif W.; Wild G.; ; Lakatos P. |
2023 |
Article |
0 |
7 |
Stable Incidence and Risk Factors of Colorectal Cancer in Ulcerative Colitis: A Population-Based Cohort Between 1977–2020
|
; Golovics P.; ; Lakatos L.; Lakatos P.; K?rti Z.; D?vid G.; Erd?lyi Z.; ; Pand?r T. |
2023 |
Short Survey |
0 |
8 |
FAIL-T (AFP, AST, tumor sIze, ALT, and Tumor number): a model to predict intermediate-stage HCC patients who are not good candidates for TACE
|
; Sripongpun P.; ; Wetwittayakhlang P.; Jandee S.; Chamroonkul N.; Piratvisuth T. |
2023 |
Article |
0 |
9 |
Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977–2020
|
Wetwittayakhlang P.; ; Golovics P.; ; Pand?r T.; ; Erd?lyi Z.; Szita I.; Lakatos L. |
2023 |
Article |
0 |
10 |
Long-term Colectomy Rates of Ulcerative Colitis over 40 Years of Different Therapeutic Eras-Results from a Western Hungarian Population-based Inception Cohort Between 1977 and 2020
|
Wetwittayakhlang P.; G?nczi L.; Lakatos L.; K?rti Z.; Golovics P.; Pand?r T.; D?vid G.; Erd?lyi Z.; Szita I.; Lakatos P. |
2023 |
Article |
1 |
11 |
The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer
|
Wetwittayakhlang P.; Tselekouni P.; Al-Jabri R.; Bessissow T.; Lakatos P. |
2023 |
Review |
0 |
12 |
Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study
|
Wetwittayakhlang P.; Golovics P.; Al-Khoury A.; Ganni E.; Hahn G.; Cohen A.; Wyse J.; Bradette M.; Bessissow T.; Afif W.; Wild G.; Bitton A.; Lakatos P. |
2022 |
Article |
0 |
13 |
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
|
Hahn G.; LeBlanc J.; Golovics P.; Wetwittayakhlang P.; Qatomah A.; Wang A.; Boodaghians L.; ; ; Wild G.; Afif W.; Bitton A.; Lakatos P.; Bessissow T. |
2022 |
Article |
0 |
14 |
The effect of fiber supplementation on the prevention of diarrhea in hospitalized patients receiving enteral nutrition: A meta-analysis of randomized controlled trials with the GRADE assessment
|
Kaewdech A.; Sripongpun P.; Wetwittayakhlang P.; Churuangsuk C. |
2022 |
Review |
0 |
15 |
Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996–2015
|
Golovics P.; Verdon C.; Wetwittayakhlang P.; Filliter C.; G?nczi L.; Hahn G.; Wild G.; Afif W.; Bitton A.; Bessissow T.; Brassard P.; Lakatos P. |
2022 |
Article |
0 |
16 |
Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn's Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance
|
Hahn G.; Wetwittayakhlang P.; Afif W.; Bessissow T.; Lakatos P. |
2022 |
Review |
0 |
17 |
Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?
|
Hahn G.; Golovics P.; Wetwittayakhlang P.; Al-Khoury A.; Bessissow T.; Lakatos P. |
2022 |
Review |
0 |
18 |
The Optimal Management of Fistulizing Crohn’s Disease: Evidence beyond Randomized Clinical Trials
|
Wetwittayakhlang P.; Al-Khoury A.; Hahn G.; Lakatos P. |
2022 |
Review |
0 |
19 |
Safety of Biological Therapies in Elderly Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
|
Hahn G.; Golovics P.; Wetwittayakhlang P.; Santa Maria D.; Britto U.; Wild G.; Afif W.; Bitton A.; Bessissow T.; Lakatos P. |
2022 |
Review |
0 |
20 |
Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
|
Wetwittayakhlang P.; Albader F.; Golovics P.; Hahn G.; Bessissow T.; Bitton A.; Afif W.; Wild G.; Lakatos P. |
2021 |
Article |
5 |
21 |
Treatment targets in ulcerative colitis: Is it time for all in, including histology?
|
Wetwittayakhlang P.; Lontai L.; G?nczi L.; Golovics P.; Hahn G.; Bessissow T.; Lakatos P. |
2021 |
Review |
3 |
22 |
Comforting Data on the Incidence of Rectal Cancer after Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!
|
Wetwittayakhlang P.; Lakatos P. |
2021 |
Editorial |
1 |
23 |
Efficacy of prucalopride in critically ill patients with paralytic ileus: A pilot randomized double-blind placebo-controlled trial
|
Jandee S.; Wetwittayakhlang P.; Boonsri P. |
2021 |
Article |
0 |
24 |
Correlation of Transient Elastography and Biliary Cirrhosis in Longterm Survivors of Biliary Atresia
|
Srisuwan W.; Laochareonsuk W.; Wetwittayakhlang P.; Kritsaneepaiboon S.; Sangkhathat S. |
2021 |
Article |
0 |
25 |
Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients
|
Wetwittayakhlang P.; Rujeerapaiboon N.; Wetwittayakhlung P.; Sripongpun P.; Pruphetkaew N.; Jandee S.; Chamroonkul N.; Piratvisuth T. |
2021 |
Article |
4 |
26 |
Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn’s disease: A multicenter study from Asia
|
Limsrivilai J.; Lee C.; Prueksapanich P.; Harinwan K.; Sudcharoen A.; Cheewasereechon N.; Aniwan S.; Sripongpan P.; Wetwittayakhlang P.; Pongpaibul A.; Sanpavat A.; Pausawasdi N.; Charatcharoenwitthaya P.; Higgins P.; Ng S. |
2020 |
Article |
4 |
27 |
Primary hepatic angiosarcoma: A rare liver malignancy-varying manifestations but grave prognosis
|
Rujeerapaiboon N.; Wetwittayakhlang P. |
2020 |
Article |
4 |
28 |
Re-bleeding and its predictors after capsule endoscopy in patients with obscure gastrointestinal bleeding in long-term follow-up
|
Wetwittayakhlang P.; Wonglhow J.; Netinatsunton N.; Chamroonkul N.; Piratvisuth T. |
2019 |
Article |
8 |
29 |
Primary Gastrointestinal Amyloidosis: An Unusual Cause of Acute Intestinal Pseudo-Obstruction
|
Wetwittayakhlang P.; Sripongpun P.; Jandee S. |
2019 |
Article |
2 |